Reilly Financial Advisors’s West Pharmaceutical WST Stock Holding History

Reilly Financial Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-105	Closed	-$16K	–	950
2019 Q4	$16K	Hold	105	–	–	﹤0.01%	550
2019 Q3	$15K	Hold	105	–	–	﹤0.01%	569
2019 Q2	$13K	Hold	105	–	–	﹤0.01%	620
2019 Q1	$12K	Hold	105	–	–	﹤0.01%	645
2018 Q4	$10K	Hold	105	–	–	﹤0.01%	657
2018 Q3	$13K	Hold	105	–	–	﹤0.01%	645
2018 Q2	$10K	Hold	105	–	–	﹤0.01%	673
2018 Q1	$9K	Buy	+105	New	+$9.82K	﹤0.01%	683

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Reilly Financial Advisors's WST Position: Q1 2020 in Review

Reilly Financial Advisors sold out of West Pharmaceutical (WST) in Q1 2020, closing a stake of 105 shares — an estimated $16K sold.

Reilly Financial Advisors first reported a position in WST in Q1 2018 and held it in 8 quarters. The position peaked at $16K in Q4 2019. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

Reilly Financial Advisors reported no remaining West Pharmaceutical position as of Q1 2020 after selling out during the quarter.
Reilly Financial Advisors sold 105 West Pharmaceutical shares in Q1 2020, an estimated $16K.
Reilly Financial Advisors first reported a position in West Pharmaceutical in Q1 2018 and held it in 8 quarters.
Reilly Financial Advisors's West Pharmaceutical position peaked at $16K in Q4 2019.
468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Reilly Financial Advisors's 13F filing for Q1 2020, filed 13 Apr 2020.